218 related articles for article (PubMed ID: 11287627)
1. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
[TBL] [Abstract][Full Text] [Related]
2. p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis.
Buchold GM; Magyar PL; Arumugam R; Lee MM; O'Brien DA
Mol Reprod Dev; 2007 Aug; 74(8):997-1007. PubMed ID: 17342741
[TBL] [Abstract][Full Text] [Related]
3. INK4d-deficient mice are fertile despite testicular atrophy.
Zindy F; van Deursen J; Grosveld G; Sherr CJ; Roussel MF
Mol Cell Biol; 2000 Jan; 20(1):372-8. PubMed ID: 10594039
[TBL] [Abstract][Full Text] [Related]
4. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
[TBL] [Abstract][Full Text] [Related]
5. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.
Kovalev GI; Franklin DS; Coffield VM; Xiong Y; Su L
J Immunol; 2001 Sep; 167(6):3285-92. PubMed ID: 11544316
[TBL] [Abstract][Full Text] [Related]
6. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
[TBL] [Abstract][Full Text] [Related]
7. Mice lacking cyclin-dependent kinase inhibitor p19Ink4d show strain-specific effects on male reproduction.
Buchold GM; Magyar PL; O'Brien DA
Mol Reprod Dev; 2007 Aug; 74(8):1008-20. PubMed ID: 17393423
[TBL] [Abstract][Full Text] [Related]
8. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
[TBL] [Abstract][Full Text] [Related]
9. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.
Fink JR; LeBien TW
Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189
[TBL] [Abstract][Full Text] [Related]
10. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
[TBL] [Abstract][Full Text] [Related]
11. Interplay between p53 and Ink4c in spermatogenesis and fertility.
Zalzali H; Rabeh W; Najjar O; Abi Ammar R; Harajly M; Saab R
Cell Cycle; 2018; 17(5):643-651. PubMed ID: 29334315
[TBL] [Abstract][Full Text] [Related]
12. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.
Komata T; Kanzawa T; Takeuchi H; Germano IM; Schreiber M; Kondo Y; Kondo S
Br J Cancer; 2003 Apr; 88(8):1277-80. PubMed ID: 12698196
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
[TBL] [Abstract][Full Text] [Related]
15. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit.
Cunningham JJ; Levine EM; Zindy F; Goloubeva O; Roussel MF; Smeyne RJ
Mol Cell Neurosci; 2002 Mar; 19(3):359-74. PubMed ID: 11906209
[TBL] [Abstract][Full Text] [Related]
16. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
[TBL] [Abstract][Full Text] [Related]
17. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
[TBL] [Abstract][Full Text] [Related]
18. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases.
Zindy F; Cunningham JJ; Sherr CJ; Jogal S; Smeyne RJ; Roussel MF
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13462-7. PubMed ID: 10557343
[TBL] [Abstract][Full Text] [Related]
19. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths.
Renner C; Baumgartner R; Noegel AA; Holak TA
J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685
[TBL] [Abstract][Full Text] [Related]
20. A potential role for p15(Ink4b) and p57(Kip2) in liver development.
Awad MM; Sanders JA; Gruppuso PA
FEBS Lett; 2000 Oct; 483(2-3):160-4. PubMed ID: 11042273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
